Literature DB >> 19644735

Regulation of Plasmodium falciparum Pfnek3 relies on phosphorylation at its activation loop and at threonine 82.

Huiyu Low1, Chun Song Chua, Tiow-Suan Sim.   

Abstract

A mitogen-activated protein kinase (MAPK), Pfmap2, has been identified in Plasmodium falciparum. However, its bona fide activator remains elusive as no MAPK kinase (MAPKK) homologues have been found so far. Instead, Pfnek3, a NIMA (never in mitosis, Aspergillus)-related kinase, was earlier reported to display a MAPKK-like activity due to its activating effect on Pfmap2. In this study, the regulatory mechanism of Pfnek3 was investigated. Pfnek3 was found to possess a SSEQSS motif within its activation loop that fulfills the consensus SXXXS/T phospho-activating sequence of MAPKKs. Functional analyses of the SSEQSS motif by site-directed mutagenesis revealed that phosphorylation of residues S221 and S226 is essential for mediating Pfnek3 activity. Moreover, via tandem mass-spectrometry, residue T82 was uncovered as an additional phosphorylation site involved in Pfnek3 activation. Collectively, these results provide valuable insights into the potential in vivo regulation of Pfnek3, with residues T82, S221 and S226 functioning as phospho-activating sites.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19644735     DOI: 10.1007/s00018-009-0101-8

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  26 in total

Review 1.  The protein kinase activity modulation sites: mechanisms for cellular regulation - targets for therapeutic intervention.

Authors:  R A Engh; D Bossemeyer
Journal:  Adv Enzyme Regul       Date:  2001

2.  Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search.

Authors:  Andrew Keller; Alexey I Nesvizhskii; Eugene Kolker; Ruedi Aebersold
Journal:  Anal Chem       Date:  2002-10-15       Impact factor: 6.986

Review 3.  Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification.

Authors:  S K Hanks; T Hunter
Journal:  FASEB J       Date:  1995-05       Impact factor: 5.191

Review 4.  Active and inactive protein kinases: structural basis for regulation.

Authors:  L N Johnson; M E Noble; D J Owen
Journal:  Cell       Date:  1996-04-19       Impact factor: 41.582

5.  Constitutive activation of Mek1 by mutation of serine phosphorylation sites.

Authors:  W Huang; R L Erikson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

Review 6.  Never say never. The NIMA-related protein kinases in mitotic control.

Authors:  Matthew J O'Connell; Michael J E Krien; Tony Hunter
Journal:  Trends Cell Biol       Date:  2003-05       Impact factor: 20.808

7.  Isolation of a functional homolog of the cell cycle-specific NIMA protein kinase of Aspergillus nidulans and functional analysis of conserved residues.

Authors:  R T Pu; G Xu; L Wu; J Vierula; K O'Donnell; X S Ye; S A Osmani
Journal:  J Biol Chem       Date:  1995-07-28       Impact factor: 5.157

8.  Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition.

Authors:  Jeffrey F Ohren; Huifen Chen; Alexander Pavlovsky; Christopher Whitehead; Erli Zhang; Peter Kuffa; Chunhong Yan; Patrick McConnell; Cindy Spessard; Craig Banotai; W Thomas Mueller; Amy Delaney; Charles Omer; Judith Sebolt-Leopold; David T Dudley; Iris K Leung; Cathlin Flamme; Joseph Warmus; Michael Kaufman; Stephen Barrett; Haile Tecle; Charles A Hasemann
Journal:  Nat Struct Mol Biol       Date:  2004-11-14       Impact factor: 15.369

9.  Activation of MEK family kinases requires phosphorylation of two conserved Ser/Thr residues.

Authors:  C F Zheng; K L Guan
Journal:  EMBO J       Date:  1994-03-01       Impact factor: 11.598

Review 10.  Protein kinases of the human malaria parasite Plasmodium falciparum: the kinome of a divergent eukaryote.

Authors:  Pauline Ward; Leila Equinet; Jeremy Packer; Christian Doerig
Journal:  BMC Genomics       Date:  2004-10-12       Impact factor: 3.969

View more
  2 in total

1.  In silico characterization of an atypical MAPK phosphatase of Plasmodium falciparum as a suitable target for drug discovery.

Authors:  Christopher O Campbell; Daniel N Santiago; Wayne C Guida; Roman Manetsch; John H Adams
Journal:  Chem Biol Drug Des       Date:  2014-05-12       Impact factor: 2.817

2.  Plasmodium falciparum possesses a unique dual-specificity serine/threonine and tyrosine kinase, Pfnek3.

Authors:  Huiyu Low; Chun Song Chua; Tiow-Suan Sim
Journal:  Cell Mol Life Sci       Date:  2011-11-25       Impact factor: 9.261

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.